Delivery Order SPE2DB20D1100-SPE2DB25FA9F6
Award Date 3/5/25
Potential Completion Date 3/6/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order for AZSTARYS Capsules (39.2mg/7.8mg) valued at $1,567.95 by the Defense Department's Medical Supply Chain division. This competitively awarded, non-set-aside contract is priced on a firm fixed-price basis with a completion date of June 3, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations as a major healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $4,782.29 to AmerisourceBergen Drug Corp for AZSTARYS 39.2 mg-7.8 mg capsules (100-count) on August 19, 2025, with completion scheduled for August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Azstarys 39.2 mg-7.8 mg capsules (100-count packaging) with a ceiling value of $1,436.84. This competitively awarded, non-set-aside delivery order represents a firm fixed-price contract with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- This is a $1,797.13 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product, with a performance period ending on May 22, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,277.09, is for the provision of AZSTARYS CAPS 52.3MG/10.4MG, a pharmaceutical product. The award has an ultimate completion date of January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- This is a $1,304.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, with a performance period ending on February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for AZSTARYS Capsules 39.2mg/7.8mg, a pharmaceutical product used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $5,307.13, is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,668.99 on August 18, 2025, for the supply of Azstarys 52.3 mg-10.4 mg capsules (100-count unit). This firm fixed-price contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 19, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, reflecting the...
- This is a firm-fixed-price delivery order for $3,808.23 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is not set aside and does not appear to be associated with a larger contract vehicle. The delivery order has an ultimate completion date of June 23, 2025....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The total ceiling value of the contract is $1,630.88, with a period of performance through June 11, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open...